Pfizer in talks on $5 billion acquisition: media - RFI English


8/6/2022 12:00:00 AM2 years 9 months ago
by RFI

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

New York (AFP) American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Str… [+1154 chars]

full article...